Green Chemistry in the Pharmaceutical Industry is a multidisciplinary endeavour, requiring contributions from chemists, chemical engineers and molecular biologists. The book contains several convincing case histories illustrating howthis multidisciplinarity has yielded efficient and environmentally friendly processes. The book covers all aspects of Green Chemistry in the PharmaceuticalIndustry from simple molecules to complex proteins, from drug discovery to the fate of pharmaceuticals in the environment.Peter Dunn is the global head of Green Chemistry at Pfizer. He did his PhD with Professor Charles Rees at Imperial College, London followed by postdoctoralresearch with Professor Albert Eschenmoser (ETH, Zurich) and Henry Rapoport (University of California, Berkeley). He joined Pfizer in 1989 and worked in the Chemical R&D department for 17years during which time he became the inventorof processes to make a number of drugs including ViagraTM and EnablexTM. He took up his current post in Green Chemistry in 2006 and became co-chair of the American Chemical Society Green Chemistry Institute Pharmaceutical Roundtable in 2007. Michael Williams joined Pfizer in 1972 following his PhD with Professor Charles Rees (University of Liverpool), and rose to become Executive Director and Departmental Head of UK Chemical R&D in 2003. His mid-career responsibilities included the Medicinal Chemistry interface, outsourcing initiatives andtechnology adoption. In addition to his experience with about 50 early drug candidates, he played a significant role in the late development, filing and commercialization of many agents including ZoloftTM, ViagraTM and RelpaxTM. Since retiring from Pfizer in late 2007, he has become an independent CMC consultant. Andy Wells is a Principal Scientist in the AstraZeneca Global Process R&D Group. Following a BSc and PhD at Essex University he joined Chemical Development at SmithKline & French in 1986, (SmithKline Beecham in 1989). Experienced in all aspects of organic synthesis and scale-up, he has special interests in chemo-catalysis, biocatalysis and green chemistry. Whilst at SmithKline Beecham he won a corporate Green Chemistry/Technology award in 1999. He currently leads the AstraZeneca Green Chemistry group and is co-chair of American ChemicalSociety Green Chemistry Institute Pharmaceutical Roundtable. He is also on the international advisory board of the journal, ChemSusChem.
- ISBN: 978-3-527-32418-7
- Editorial: Wiley-VCH
- Encuadernacion: Cartoné
- Páginas: 388
- Fecha Publicación: 10/03/2010
- Nº Volúmenes: 1
- Idioma: Inglés